Joseph K. Belanoff - 29 May 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 16:05:24 UTC
Prior SEC filing
05 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff

Key filing fact

Joseph K. Belanoff filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 02 Jun 2026.

Key facts

  • This page summarizes Joseph K. Belanoff's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 05 May 2026.
  • Current net transaction value: -$895,252.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001286199 Primary reporting owner

BELANOFF JOSEPH K

Relationship
Chief Executive Officer, Director
Address
C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Gift

Transaction value
Shares
-300,000
Change %
-10%
Price
$0.000000*
Shares after
2,578,326
Date
29 May 2026
Ownership
Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Footnotes
F1
CORT transaction

Common Stock

Gift

Transaction value
Shares
+150,000
Change %
Price
$0.000000*
Shares after
150,000
Date
29 May 2026
Ownership
Joseph K. Belanoff 2026 Grantor Retained Annuity Trust
Footnotes
F2, F3
CORT transaction

Common Stock

Gift

Transaction value
Shares
+150,000
Change %
Price
$0.000000*
Shares after
150,000
Date
29 May 2026
Ownership
Katherine A. Blenko 2026 Grantor Retained Annuity Trust
Footnotes
F4, F5
CORT transaction

Common Stock

Sale

Transaction value
$895,252
Shares
-12,837
Change %
-0.5%
Price
$69.74
Shares after
2,565,489
Date
01 Jun 2026
Ownership
Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Footnote F2

Transfer of shares without consideration to the Joseph K. Belanoff 2026 Grantor Retained Annuity Trust.

Footnote F3

Shares are held by Joseph K. Belanoff 2026 Grantor Retained Annuity Trust, of which the Reporting Person is the trustee.

Footnote F4

Transfer of shares without consideration to the Katherine A. Blenko 2026 Grantor Retained Annuity Trust.

Footnote F5

Shares are held by Katherine A. Blenko 2026 Grantor Retained Annuity Trust, of which the spouse of the Reporting Person is the trustee.

Footnote F6

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .